Table 3.
Available meningitis panels
| Targets | BioFire ME |
|---|---|
| Bacteria | |
| Escherichia coli K1 | ✓ |
| Haemophilus influenzae | ✓ |
| Listeria monocytogenes | ✓ |
| Neisseria meningitidis | ✓ |
| Streptococcus agalactiae | ✓ |
| Streptococcus pneumoniae | ✓ |
| Viruses | |
| Cytomegalovirus (CMV) | ✓ |
| Enterovirus | ✓ |
| Herpes simplex virus 1 (HSV-1) | ✓ |
| Herpes simplex virus 2 (HSV-2) | ✓ |
| Human herpesvirus 6 (HHV-6) | ✓ |
| Human parechovirus | ✓ |
| Varicella zoster virus (VZV) | ✓ |
| Fungi | |
| Yeast | |
| Cryptococcus neoformans/gattii | ✓ |
| Panel information | |
| Platform | FilmArray system |
| Targets in panel | 14 |
| Throughput | Low-Medium |
| Hands on time | <5 min |
| Time to result | 1 h |
QIAstat-Dx Meningitis/Encephalitis and the central nervous system panel (CNS) from GeneMark Dx are in development.